Yahoo Canada Web Search

Search results

  1. Feb 11, 2024 · An international animal health company with facilities in Prince Edward Island has been sold to a global powerhouse to the tune of $1.3 billion. Elanco Animal Health entered into an agreement to ...

  2. Feb 6, 2024 · February 6, 2024. PEI fish health assets a key part of the transaction. Charlottetown, PE – Elanco Animal Health has announced it has entered into an agreement to sell its aqua business to Merck Animal Health for approximately $1.3 billion in cash. Elanco’s aqua business includes products across both warm-water and cold-water species ...

  3. Mar 12, 2018 · Merck Animal Health helps aquaculture producers and conservationists cultivate and maintain healthy and sustainable aquatic ecosystems. Our industry-leading biopharmaceutical and technology solutions monitor for insight, optimize for precision, and benchmark for performance.

  4. Elanco Canada. Elanco is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

  5. May 26, 2021 · EVAH Corp. today announced the signing of four contracts with Elanco Animal Health to acquire and develop technologies in animal health, including the Elanco facility in Prince Edward Island. EVAH is a biotechnology company specializing in the development of biologicals to help prevent bacterial diseases in food animals and microbiome solutions for growth performance.

  6. Feb 7, 2024 · Feb 07, 2024. Elanco Aqua’s P.E.I. office (Photo: Google Maps) Indiana pharmaceuticals giant Elanco Animal Health has sold its Prince Edward Island operation, a stalwart of the province’s life sciences cluster, to Merck & Co. for US$1.3 billion, or C$1.75 billion. Elanco’s business unit for aquaculture pharmaceuticals, which began as one ...

  7. People also ask

  8. Dec 24, 2019 · Elanco Animal Health Incorporated (NYSE: ELAN) has signed an agreement to sell its Victoria, Prince Edward Island (PEI) aqua research and development facility to The Center for Aquaculture Technologies Canada, a leading aquaculture R&D and contract research services company with an established presence in PEI. The site was added to the Elanco footprint as part of the Novartis acquisition in ...

  1. People also search for